Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy

Introduction: Circulating autoantibodies against the podocyte surface protein nephrin have recently been described in patients with podocytopathies, that is, minimal change disease, primary focal segmental glomerulosclerosis, and childhood idiopathic nephrotic syndrome. Their high specificity for po...

Full description

Saved in:
Bibliographic Details
Main Authors: Felicitas E. Hengel, Michelle C.Z. Chong, Wing Yin Leung, Silke Dehde, Anne Mühlig, Matthias Janneck, Henry H.L. Wu, Tobias B. Huber, Arvind Ponnusamy, Nicola M. Tomas
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Kidney International Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S246802492500292X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839604044436340736
author Felicitas E. Hengel
Michelle C.Z. Chong
Wing Yin Leung
Silke Dehde
Anne Mühlig
Matthias Janneck
Henry H.L. Wu
Tobias B. Huber
Arvind Ponnusamy
Nicola M. Tomas
author_facet Felicitas E. Hengel
Michelle C.Z. Chong
Wing Yin Leung
Silke Dehde
Anne Mühlig
Matthias Janneck
Henry H.L. Wu
Tobias B. Huber
Arvind Ponnusamy
Nicola M. Tomas
author_sort Felicitas E. Hengel
collection DOAJ
description Introduction: Circulating autoantibodies against the podocyte surface protein nephrin have recently been described in patients with podocytopathies, that is, minimal change disease, primary focal segmental glomerulosclerosis, and childhood idiopathic nephrotic syndrome. Their high specificity for podocytopathies in combination with a strong correlation with disease activity hold the potential for a non-invasive diagnosis, but prospective data are lacking. Methods: Here, we describe 3 patients with contraindications or unwillingness for a kidney biopsy, hampering a timely histological diagnosis and choice of appropriate therapy. Results: In all patients, antinephrin autoantibodies were detected by quantitative immunoprecipitation, prompting the initiation of adequate treatment. These interventions induced a decrease in antinephrin autoantibody levels and clinical remission. Conclusion: Our study highlights the potential of antinephrin autoantibody measurement for a noninvasive diagnosis of antinephrin-associated podocytopathy.
format Article
id doaj-art-dfb054a5617b48ad9ad83d5058d2bc72
institution Matheson Library
issn 2468-0249
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-dfb054a5617b48ad9ad83d5058d2bc722025-08-02T04:47:22ZengElsevierKidney International Reports2468-02492025-08-0110828002804Non-invasive Diagnosis of Antinephrin–Associated PodocytopathyFelicitas E. Hengel0Michelle C.Z. Chong1Wing Yin Leung2Silke Dehde3Anne Mühlig4Matthias Janneck5Henry H.L. Wu6Tobias B. Huber7Arvind Ponnusamy8Nicola M. Tomas9III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UKDepartment of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UKIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of General Internal Medicine and Nephrology, Albertinen Hospital Hamburg, Hamburg, GermanyDepartment of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyRenal Research, Kolling Institute of Medical Research, Royal North Shore Hospital and The University of Sydney, Sydney, New Soulth Wales, AustraliaIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Correspondence: Tobias B. Huber, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Arvind Ponnusamy, RenalDepartment, Royal Preston Hospital, PR29HT Preston, UK.III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Nicola M. Tomas, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.Introduction: Circulating autoantibodies against the podocyte surface protein nephrin have recently been described in patients with podocytopathies, that is, minimal change disease, primary focal segmental glomerulosclerosis, and childhood idiopathic nephrotic syndrome. Their high specificity for podocytopathies in combination with a strong correlation with disease activity hold the potential for a non-invasive diagnosis, but prospective data are lacking. Methods: Here, we describe 3 patients with contraindications or unwillingness for a kidney biopsy, hampering a timely histological diagnosis and choice of appropriate therapy. Results: In all patients, antinephrin autoantibodies were detected by quantitative immunoprecipitation, prompting the initiation of adequate treatment. These interventions induced a decrease in antinephrin autoantibody levels and clinical remission. Conclusion: Our study highlights the potential of antinephrin autoantibody measurement for a noninvasive diagnosis of antinephrin-associated podocytopathy.http://www.sciencedirect.com/science/article/pii/S246802492500292Xantinephrin autoantibodiesminimal change diseasepodocytopathyserology
spellingShingle Felicitas E. Hengel
Michelle C.Z. Chong
Wing Yin Leung
Silke Dehde
Anne Mühlig
Matthias Janneck
Henry H.L. Wu
Tobias B. Huber
Arvind Ponnusamy
Nicola M. Tomas
Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
Kidney International Reports
antinephrin autoantibodies
minimal change disease
podocytopathy
serology
title Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
title_full Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
title_fullStr Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
title_full_unstemmed Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
title_short Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
title_sort non invasive diagnosis of antinephrin associated podocytopathy
topic antinephrin autoantibodies
minimal change disease
podocytopathy
serology
url http://www.sciencedirect.com/science/article/pii/S246802492500292X
work_keys_str_mv AT felicitasehengel noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT michelleczchong noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT wingyinleung noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT silkedehde noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT annemuhlig noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT matthiasjanneck noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT henryhlwu noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT tobiasbhuber noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT arvindponnusamy noninvasivediagnosisofantinephrinassociatedpodocytopathy
AT nicolamtomas noninvasivediagnosisofantinephrinassociatedpodocytopathy